| 10851367 |
Tissue-specific genome engineering using CRISPR-Cas9 |
Spiros Liras, Benjamin Thuma, Jennifer A. Doudna, Romain Rouet |
2020-12-01 |
| 10813942 |
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR |
Spiros Liras, Benjamin Thuma |
2020-10-27 |
| 10376531 |
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR |
Spiros Liras, Benjamin Thuma |
2019-08-13 |
| 10039778 |
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR |
Spiros Liras, Benjamin Thuma |
2018-08-07 |
| 9617293 |
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR |
Spiros Liras, Benjamin Thuma |
2017-04-11 |
| 9439901 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives |
— |
2016-09-13 |
| 9439902 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives |
— |
2016-09-13 |
| 9340553 |
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR |
Spiros Liras, Benjamin Thuma |
2016-05-17 |
| 9308204 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives |
— |
2016-04-12 |
| 8669380 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives |
— |
2014-03-11 |
| 8080580 |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives |
Benjamin Micah Collman |
2011-12-20 |
